Đang chuẩn bị liên kết để tải về tài liệu:
Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: A retrospective study

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Prognostic biomarkers provide essential information about a patient’s overall outcome. However, existing biomarkers are limited in terms of either sample collection, such as requiring tissue specimens, or the process, such as prolonged time for analysis. | Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer A retrospective study

TÀI LIỆU LIÊN QUAN

Combination of preoperative neutrophillymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: A superior prognostic factor of endometrial cancer

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Clinical utility of blood neutrophillymphocyte ratio in Japanese COPD patients

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer